Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evalu (Q42905560)
Jump to navigation
Jump to search
scientific article published on 17 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evalu |
scientific article published on 17 September 2010 |
Statements
Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study (English)
Jean A Hurteau
Mark F Brady
Kathleen M Darcy
William P McGuire
Pamela Edmonds
Michael L Pearl
Iouri Ivanov
Krishnansu S Tewari
Robert S Mannel
Kristine Zanotti
17 September 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference